tiprankstipranks
CB Scientific Inc (CBSC)
OTHER OTC:CBSC
US Market

CB Scientific (CBSC) Price & Analysis

14 Followers

CBSC Stock Chart & Stats

$0.04
$0.00(0.00%)
At close: 4:00 PM EST
$0.04
$0.00(0.00%)

CBSC FAQ

What was CB Scientific Inc’s price range in the past 12 months?
CB Scientific Inc lowest stock price was $0.01 and its highest was $0.06 in the past 12 months.
    What is CB Scientific Inc’s market cap?
    CB Scientific Inc’s market cap is $4.96M.
      When is CB Scientific Inc’s upcoming earnings report date?
      The company’s upcoming earnings report date is not yet available.
      How were CB Scientific Inc’s earnings last quarter?
      Currently, no data Available
      Is CB Scientific Inc overvalued?
      According to Wall Street analysts CB Scientific Inc’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
        Does CB Scientific Inc pay dividends?
        CB Scientific Inc does not currently pay dividends.
        What is CB Scientific Inc’s EPS estimate?
        CB Scientific Inc’s EPS estimate for its next earnings report is not yet available.
        How many shares outstanding does CB Scientific Inc have?
        CB Scientific Inc has 165,438,570 shares outstanding.
          What happened to CB Scientific Inc’s price movement after its last earnings report?
          Currently, no data Available
          Which hedge fund is a major shareholder of CB Scientific Inc?
          Currently, no hedge funds are holding shares in CBSC
          What is the TipRanks Smart Score and how is it calculated?
          Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

            Company Description

            CB Scientific Inc

            Operating globally through its international subsidiaries, Cardiac Biotech Solutions Inc. delivers advanced products and services for non-invasive, mobile cardiac monitoring. The company's portfolio includes FDA and CE-approved EKG devices, sophisticated cloud-based data acquisition software, and intuitive smartphone applications compatible with both iOS and Android platforms. These solutions are designed to boost patient engagement for individuals prone to irregular heart rhythms, simultaneously providing medical professionals with highly accurate diagnostic insights. Furthermore, its wholly owned U.S. subsidiary, My-Cardia (USA), Inc., focuses on creating wearable ECG recording devices that patients can utilize in an ambulatory setting for periods extending up to 30 days.
            Similar Stocks
            Company
            Price & Change
            Follow
            GlucoTrack
            Femasys
            WORK Medical Technology Group LTD
            Popular Stocks